Founding Partners

Lloyd is a Partner and Co-Founder of Nelson Advisors. He brings 12+ years of successful HealthTech entrepreneurial experience having founded and exited various Healthcare Technology companies including Zesty in 2020 to Induction Healthcare Group PLC (FTSE:INHC).

Prior to his HealthTech ventures, Lloyd held senior business development, marketing, strategy and corporate development roles at Kelkoo, Yahoo! UK, Yahoo! Europe and Badoo from 2000 to 2012.

Lloyd is a Health Executive in Residence at the UCL Global Business School for Health, Mentor for Oxford Venture Capital Network and Oxford MedTech Society.  He was a Founder of The Future Health community in 2024 and Founding Member of the Digital Healthcare Council in 2017.

He led the Coadec-TechUK delegations sent to the European Parliament in Brussels in Sept 2015 and March 2016 to discuss the General Data Protection Regulation and EU Digital Single Market.

Lloyd was asked to judge the Digital Health PitchFest Awards in 2022, 2023, HealthInvestor Awards in 2024, 2025, HealthTech Awards at Healthcare Summit 2025 and Digital Health Awards at HLTH 2025.

He is a Non Executive Director and Advisor for various UK Digital Health and Health Tech companies ranging from Veterinary TeleHealth, Digital MSK, Workforce Management to Healthcare AI and Consumer Healthcare.

HealthTech Exits > 2020 and 2024

Paul is a Partner and Co-Founder of Nelson Advisors.  He brings more than a decade of global M&A and capital raising expertise, and 10 years of entrepreneurial experience having founded and exited from 2 early-stage companies, most recently in metabolic HealthTech.

Prior to his early-stage ventures, Paul held investment and strategy roles at Invesco, and senior investment banking advisory roles at Credit Suisse where his transaction experience included over £50 Billion of M&A and £40 Billion of equity/financing.

Paul remains an active Board Advisor to a number of early-stage tech companies across the health/med tech, fintech and consumer sectors. Paul has an honours degree in Economics from Queen’s University (Canada) and an MBA from London Business School.

His extensive corporate finance experience includes $50+ Billion of Mergers & Acquisitions and $40+ Billion equity/financing transactions across US, UK, Ireland, Sweden, Denmark, Switzerland, Germany, Austria, Italy, Poland, Ukraine, Russia, Kazakhstan, Hong Kong, Singapore and Australia.

As Co-Founder of Neutrally, Paul focused on intercepting chronic lifestyle disease with data-led habit change around nutrition, exercise, sleep + mental well-being. His research led to the commercial application of the future of weight management, wellness & longevity.

HealthTech Exits > 2019 and 2024